Prevention First

Vaccination at the Heart of Public Health. Vaccines Europe calls on EU policy-makers to develop a comprehensive vaccination strategy through five core policy asks.

Read more

Vaccine Market Access in the EU

How long for a vaccine to reach European Population? 6,4 years is the median time lag between marketing authorisation and effective population access

Find out more

Vaccines Europe at a glance

Vaccines Europe acts as the cohesive voice of the Europe-based vaccine industry sector and is a trusted partner for public authorities. Find out more about our association and contribution to Europe.

Start Prezi

The vaccine industry
in figures

With 47% growth in R&D investment over the past eight years and over 70% of current R&D projects based on new antigens and new combinations, Vaccines Europe members highly contribute to innovation.

Find out more

An industry for healthy lives

As the EU-wide recognised vaccine industry stakeholder, Vaccines Europe represents major innovative research-based vaccine companies operating in Europe and is currently expanding to SMEs.
Find out more about our services, the opportunites we offer and how to become a member.

Find out how to become a member

Latest News

RSS

Vaccines Europe calls for a European Influenza Day

2015 04 30 Written by Vaccines Europe

Luxembourg, April 30th, 2015 – Vaccines Europe launches a call on the European Commission and Member States to align and streamline communications activities around the seasonal influenza vaccination campaigns by setting a European Influenza Day to launch seasonal vaccination every year.

Vaccines Europe President Andrea Rappagliosi prompts the establishment of a common EU-wide day to launch the seasonal influenza vaccination campaigns across all Member States in occasion of the DG SANTÉ High- Level Hearing on Seasonal Influenza Vaccination.

The meeting, organised by the European Commission back-to-back to the Workshop on joint procurement being held in Luxembourg on 29-30 April 2015, is bringing together key stakeholders across public health, regulatory, industry and civil society to discuss concrete measures that can increase flu vaccination rates in the EU. Read more…

24 April – World Meningitis Day 2015

2015 04 24 Written by Vaccines Europe

Today is World Meningitis Day. It is estimated that every year more than 1.2 million people are affected by meningitis all around the world. Meningitis is inflammation of the meninges, the covering of the brain and spinal cord. It is most often caused by infection (bacterial, viral, or fungal), but can also be produced by chemical irritation, subarachnoid haemorrhage, cancer and other conditions. Meningitis is a serious disease that can affect anyone across all ages. According to the World Health Organisation (WHO) it is fatal in 50% of cases if untreated, and may result in brain damage, hearing loss or learning disability for survivors. Read more…

20-25 April 2015: This week is European Immunisation Week

2015 04 21 Written by Vaccines Europe

This week is European Immunisation Week. Immunisation is indeed considered one of the most cost-effective public health interventions available and the WHO estimates that it saves between 2 to 3 million lives every year. Vaccines has however become victims of their own success, and with the drop-down and disappearance of several diseases thanks to vaccination programmes many people who no longer see public health risks decide not to vaccinate. Over the past years, this has resulted in several severe outbreaks in European countries of vaccine preventable diseases putting avertable strains on health and healthcare systems. According to the WHO, “2013 saw 31865 measles cases alone in Europe, an increase of 348% compared to 2007. The cost of these outbreaks in both human and monetary terms is extremely high”. Read more…

See all News